Filed: 5/15/2025ACC: 0001958125-25-000004
📋 What this filing means
CATALIO CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $411.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$411.10M
Total AUM (reported)
18.14M
Total Shares
Allocation by class
COM$282.91M68.8%
COM NEW$44.05M10.7%
SPONSORED ADR$30.47M7.4%
SHS$24.06M5.9%
SPONSORED ADS$12.20M3.0%
CALL$6.50M1.6%
COM STK$4.64M1.1%
Portfolio Concentration
Top 3$113.48M27.6%
4–10$167.12M40.7%
11–25$120.29M29.3%
Rest$10.21M2.5%
Top 3 weight
27.6%
Top 10 weight
68.3%
Voting Authority Distribution
Total shares with voting rights: 18.14M
Sole
Full voting authority
17.94M
shares
% of voting shares98.9%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
200K
shares
% of voting shares1.1%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 98.9% of voting shares
Institutional Holdings37
Rows:
BECTON DICKINSON & CO
SOLEShares203.97K
TypeSH
Market value$46.72M
11.36%
Sole
203.97K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares758.53K
TypeSH
Market value$33.47M
8.14%
Sole
758.53K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares962.88K
TypeSH
Market value$33.29M
8.10%
Sole
962.88K
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
SOLEShares435.59K
TypeSH
Market value$31.57M
7.68%
Sole
435.59K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares195.52K
TypeSH
Market value$30.47M
7.41%
Sole
195.52K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares585.81K
TypeSH
Market value$23.54M
5.73%
Sole
585.81K
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares762.23K
TypeSH
Market value$22.60M
5.50%
Sole
762.23K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.73M
TypeSH
Market value$21.30M
5.18%
Sole
1.73M
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares23.68K
TypeSH
Market value$19.56M
4.76%
Sole
23.68K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares36.50K
TypeSH
Market value$18.08M
4.40%
Sole
36.50K
Shared
0.00
None
0.00
LIVANOVA PLC
SOLEShares381.65K
TypeSH
Market value$14.99M
3.65%
Sole
381.65K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares763.47K
TypeSH
Market value$13.85M
3.37%
Sole
763.47K
Shared
0.00
None
0.00
INSPIRE MED SYS INC
SOLEShares85.88K
TypeSH
Market value$13.68M
3.33%
Sole
85.88K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares704.86K
TypeSH
Market value$12.20M
2.97%
Sole
704.86K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares160.96K
TypeSH
Market value$11.50M
2.80%
Sole
160.96K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares830.33K
TypeSH
Market value$8.80M
2.14%
Sole
830.33K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares12.26K
TypeSH
Market value$7.78M
1.89%
Sole
12.26K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$6.50M
1.58%
Sole
0.00
Shared
0.00
None
100K
SEPTERNA INC
SOLEShares1.02M
TypeSH
Market value$5.93M
1.44%
Sole
1.02M
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.09M
TypeSH
Market value$4.64M
1.13%
Sole
1.09M
Shared
0.00
None
0.00
ADAPTIVE BIOTECHNOLOGIES COR
SOLEShares611.64K
TypeSH
Market value$4.54M
1.11%
Sole
611.64K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares114.62K
TypeSH
Market value$4.48M
1.09%
Sole
114.62K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares389.38K
TypeSH
Market value$3.97M
0.97%
Sole
389.38K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares611.61K
TypeSH
Market value$3.96M
0.96%
Sole
611.61K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares355.64K
TypeSH
Market value$3.47M
0.84%
Sole
355.64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BECTON DICKINSON & COSOLE | COM | 203.97K | SH | $46.72M 11.36% | 203.97K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 758.53K | SH | $33.47M 8.14% | 758.53K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 962.88K | SH | $33.29M 8.10% | 962.88K | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPSOLE | COM | 435.59K | SH | $31.57M 7.68% | 435.59K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 195.52K | SH | $30.47M 7.41% | 195.52K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 585.81K | SH | $23.54M 5.73% | 585.81K | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 762.23K | SH | $22.60M 5.50% | 762.23K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.73M | SH | $21.30M 5.18% | 1.73M | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 23.68K | SH | $19.56M 4.76% | 23.68K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 36.50K | SH | $18.08M 4.40% | 36.50K | 0.00 | 0.00 |
LIVANOVA PLCSOLE | SHS | 381.65K | SH | $14.99M 3.65% | 381.65K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 763.47K | SH | $13.85M 3.37% | 763.47K | 0.00 | 0.00 |
INSPIRE MED SYS INCSOLE | COM | 85.88K | SH | $13.68M 3.33% | 85.88K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 704.86K | SH | $12.20M 2.97% | 704.86K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 160.96K | SH | $11.50M 2.80% | 160.96K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 830.33K | SH | $8.80M 2.14% | 830.33K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 12.26K | SH | $7.78M 1.89% | 12.26K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | CALL | 100K | SH | $6.50M 1.58% | 0.00 | 0.00 | 100K |
SEPTERNA INCSOLE | COM | 1.02M | SH | $5.93M 1.44% | 1.02M | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.09M | SH | $4.64M 1.13% | 1.09M | 0.00 | 0.00 |
ADAPTIVE BIOTECHNOLOGIES CORSOLE | COM | 611.64K | SH | $4.54M 1.11% | 611.64K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 114.62K | SH | $4.48M 1.09% | 114.62K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 389.38K | SH | $3.97M 0.97% | 389.38K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 611.61K | SH | $3.96M 0.96% | 611.61K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 355.64K | SH | $3.47M 0.84% | 355.64K | 0.00 | 0.00 |
Page 1 of 2